XT
AUTL

XTX Topco’s Autolus Therapeutics AUTL Stock Holding History

XTX Topco’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Buy
287,456
+231,051
+410% +$362K 0.01% 2539
2026
Q1 		$77.8K Sell
56,405
-72,841
-56% -$111K ﹤0.01% 3181
2025
Q4 		$257K Sell
129,246
-128,115
-50% -$197K 0.01% 2204
2025
Q3 		$419K Buy
257,361
+89,107
+53% +$174K 0.02% 1213
2025
Q2 		$384K Buy
+168,254
New +$278K 0.02% 1283
2021
Q3 		– Sell
-15,286
Closed -$101K – 682
2021
Q2 		$101K Buy
+15,286
New +$94.9K 0.03% 657

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

XTX Topco's AUTL Position: Q2 2026 in Review

XTX Topco increased its Autolus Therapeutics (AUTL) stake by 410% in Q2 2026, buying an estimated $362K and bringing the position to 287,456 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #2539.

XTX Topco first reported a position in AUTL in Q2 2021 and has held it in 6 quarters since. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • XTX Topco held 287,456 shares of Autolus Therapeutics worth $460K as of Q2 2026.
  • XTX Topco bought 231,051 Autolus Therapeutics shares in Q2 2026, an estimated $362K.
  • Autolus Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2539 holding.
  • XTX Topco first reported a position in Autolus Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.